Literature DB >> 17314112

Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure.

Gabriele Tumminello1, Patrizio Lancellotti, Mathieu Lempereur, Vincent D'Orio, Luc A Pierard.   

Abstract

AIMS: Pulmonary hypertension, a marker of poor prognosis in heart failure, may develop or increase during exercise. We sought to examine the determinants of pulmonary hypertension at rest and during exercise in heart failure patients. METHODS AND
RESULTS: Forty-six patients with left ventricular (LV) dysfunction (ejection fraction: 30 +/- 6%) underwent a semi-recumbent, incremental bicycle exercise Doppler echocardiography. LV systolic and diastolic function, pulmonary artery systolic pressure (PASP), functional mitral regurgitation (MR), and left atrial volume were quantified at rest and during exercise. Wide changes in PASP at exercise were unrelated to PASP at rest (r = 0.12). Independent predictors of PASP at rest were left atrial volume (P = 0.006), E-wave velocity (P = 0.02), mitral tenting area (P = 0.005), and mitral effective regurgitant orifice (ERO) (P = 0.02). The incidence of dyspnoea was similar in patients with and without moderately severe pulmonary hypertension at baseline. At peak exercise, LV ejection fraction (P = 0.03) and mitral ERO (P = 0.008) were independently associated with PASP. Patients with a larger exercise increase in PASP (>60 mmHg) interrupted frequently exercise for dyspnoea (70 vs. 27%; P = 0.04). A larger rise in mitral regurgitant volume during exercise emerged as the single determinant of exercise-induced increases in PASP.
CONCLUSION: In patients with HF, left atrial volume, mitral deformation, and mitral regurgitant orifice correlated with pulmonary pressure at rest, whereas dynamic MR and limited contractile reserve correlated with pulmonary pressure at exercise. The magnitude of pulmonary pressure during exercise in these patients mainly depends on dynamic MR.

Entities:  

Mesh:

Year:  2007        PMID: 17314112     DOI: 10.1093/eurheartj/ehl561

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  25 in total

Review 1.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

Review 2.  Therapeutic decision-making for patients with fluctuating mitral regurgitation.

Authors:  Patrizio Lancellotti; Khalil Fattouch; Giovanni La Canna
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

3.  Left atrial dysfunction as a determinant of pulmonary hypertension in patients with severe aortic stenosis and preserved left ventricular ejection fraction.

Authors:  Andreea Calin; Anca D Mateescu; Monica Rosca; Carmen C Beladan; Roxana Enache; Simona Botezatu; Iulian Cosei; Cosmin Calin; Marian Simion; Carmen Ginghina; Andreea C Popescu; Bogdan A Popescu
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-15       Impact factor: 2.357

Review 4.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

5.  Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Klio Papadopoulou; Tilemahos Sfetsios; Haralambos Karvounis; Hariklia Dimitroula; Despina Parcharidou; Georgios Koliakos; Alexandros Garyfallos; Ioannis Styliadis; Loukas Settas
Journal:  Clin Rheumatol       Date:  2010-06-05       Impact factor: 2.980

6.  Impact of mitral regurgitation on exercise capacity and clinical outcomes in patients with ischemic left ventricular dysfunction.

Authors:  Catherine Szymanski; Robert A Levine; Christophe Tribouilloy; Hui Zheng; Mark D Handschumacher; Ahmed Tawakol; Judy Hung
Journal:  Am J Cardiol       Date:  2011-09-21       Impact factor: 2.778

7.  Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.

Authors:  Philippe B Bertrand; Ehud Schwammenthal; Robert A Levine; Pieter M Vandervoort
Journal:  Circulation       Date:  2017-01-17       Impact factor: 29.690

8.  Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Authors:  A Rossi; F L Dini; E Agricola; P Faggiano; G Benfari; P L Temporelli; C Cucco; L Scelsi; C Vassanelli; S Ghio
Journal:  J Echocardiogr       Date:  2018-02-23

9.  Approach to patients with heart failure and pulmonary hypertension.

Authors:  Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

10.  Prevalence of ventricular discordance and its relation to functional capacity in idiopathic dilated cardiomyopathy.

Authors:  Gunnar Plehn; Julia Vormbrock; Lutz Lefringhausen; Marc van Bracht; Alexander Plehn; Thomas Butz; Hans-Joachim Trappe; Axel Meissner
Journal:  Clin Res Cardiol       Date:  2009-03-13       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.